Clinical study of FOLFIRI regimen combined with apatinib in the treatment of advanced rectal cancer during perioperative period

ABSTRACT: Interventions: experimental group:Apatinib combined with FOLFIRI Primary outcome(s): Disease-free survival time (DFS);R0 resection rate Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2685021 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR